Evaluation of novel targeting strategies to deliver engineered protein therapeutics in relevant in vitro and in vivo osteoarthritis models

Research unit

INNOSUISSE

Project number

104.824 IP-LS

Project title

Evaluation of novel targeting strategies to deliver engineered protein therapeutics in relevant in vitro and in vivo osteoarthritis models

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Medtech
Abstract (English)	Osteoarthritis(OA) is a degenerative joint disease for which no disease-modifying drugs are available. Philochem AG and ETH Zurich will develop novel immunocytokines and evaluate delivery and screening systems to select the best candidate for the clinical development of a groundbreaking OA therapy.